exercise and glp 1 Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial GLP-1 and Exercise // Why
Description
Monitoring Patients Who Take GLP-1 RAs for Weight Loss What Prescribers Should Know Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States
10.2337/db18-0155 12 MarchettiP.LupiR.BuglianiM.KirkpatrickC
Read the full study: Helen Michaela de Oliveira MS, Mariano Reynaldo Gallo Ruelas RD, Pandora Eloa Oliveira Fonseca MS, Camilo Andr Viana Diaz MS, Guilherme Oliveira de Paula MS, Pablo Ramon Fruett da Costa MD, Tariq Parker MD, PhD, Kristopher T
Glucagon-like peptide-1 and its analogues act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight
However, it's critical to understand that: No GLP-1 patch is currently approved for patient use
